US23282W6057
US23282W6057
Cytokinetics, Incorporated
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 88.039.000 | 18.474.000 | 376.6% |
| Cost of Revenue | 416.026.000 | 339.408.000 | 22.6% |
| Gross Profit | -327.987.000 | -320.934.000 | 2.2% |
| 700.297.000 | 554.722.000 | 26.2% | |
| Operating Income | -612.258.000 | -536.248.000 | 14.2% |
| Pretax Income | -784.955.000 | -589.526.000 | 33.2% |
| Net Income Common Stockholders | -784.955.000 | -589.526.000 | 33.2% |
| -- | -- | -- | |
| -- | -- | -- |